AMRN

AMARIN CORP PLC\UK

Sales chart range
Log in to watch AMRN
Latest sale
$27k
Dec 12 · Routine
Form 4 sales
130
On record
Form 144 notices
1
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleUnusual
    Jan 3 2020

    Sold 300,000 shares at $20.94 ($6.3M)

    Zakrzewski Joseph S, Director

    Sold 78% of holdings ($8.1M position)84,547 shares left1.7x usual sizeFiling

  2. 2 Form 4 salePlan not stated
    Mar 4 +61 days

    Sold 200,000 shares at $15.99 ($3.2M)

    Thero John F, President and CEO

    Sold 7.5% of holdings ($42.9M position)2.5M shares left0.5x usual sizeFiling

  3. 3 Form 4 salePlan not stated
    Nov 11 +252 days

    Sold 567,405 shares at $4.09 ($2.3M)

    Thero John F, President and CEO

    Sold 17.2% of holdings ($13.5M position)2.7M shares left2.1x usual sizeFiling

  4. 4 Form 4 saleUnusual
    Jan 27 +77 days

    Sold 421,629 shares at $8.01 ($3.4M)

    Ketchum Steven B, Chief Scientific Officer

    Sold 52.1% of holdings ($6.5M position)388,112 shares left17.9x usual sizeFiling

  5. 5 Form 4 saleUnusual
    Feb 1 +5 days

    Sold 217,728 shares at $8.06 ($1.8M)

    Ketchum Steven B, Chief Scientific Officer

    Sold 36.2% of holdings ($4.8M position)382,996 shares left6.7x usual sizeFiling

  6. 6 Form 4 saleUnusual
    Aug 12 +192 days

    Sold 120,000 shares at $5.25 ($630k)

    Kalb Michael Wayne, SVP and CFO

    Sold 36.9% of holdings ($1.7M position)205,010 shares leftFiling

  7. 7 Form 144 noticeNotice
    Dec 12 +852 days

    Filed to sell 34,131 shares ($29k)

    Ketchum Steven B, Officer

    10b5-1 planFirst sale on recordFiling

  8. 8 Form 4 saleRoutine
    Dec 12 same day

    Sold 34,131 shares at $0.79 ($27k)

    Ketchum Steven B, Chief Scientific Officer

    10b5-1 planSold 5.7% of holdings ($474k position)566,100 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (131)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for AMRN
Source
Dec 12, 2023Ketchum Steven BChief Scientific OfficerForm 4 sale34,131$27k5.7%RoutineSEC
Dec 12, 2023Ketchum Steven BOfficerForm 144 notice34,131$29kNoticeSEC
Aug 12, 2021Kalb Michael WayneSVP and CFOForm 4 sale120,000$630k36.9%UnusualSEC
Feb 1, 2021Ketchum Steven BChief Scientific OfficerForm 4 sale217,728$1.8M36.2%UnusualSEC
Jan 27, 2021Ketchum Steven BChief Scientific OfficerForm 4 sale421,629$3.4M52.1%UnusualSEC
Nov 11, 2020Thero John FPresident and CEOForm 4 sale567,405$2.3M17.2%Plan not statedSEC
Mar 4, 2020Thero John FPresident and CEOForm 4 sale200,000$3.2M7.5%Plan not statedSEC
Jan 3, 2020Zakrzewski Joseph SDirectorForm 4 sale300,000$6.3M78.0%UnusualSEC
Dec 16, 2019Zakrzewski Joseph SDirectorForm 4 sale100,000$2.6M54.2%UnusualSEC
Dec 16, 2019Berg AaronCHIEF COMMERCIAL OFFICERForm 4 sale43,253$1.1M24.4%Plan not statedSEC
Dec 16, 2019Kalb Michael WayneSVP and CFOForm 4 sale25,000$584k53.7%UnusualSEC
Nov 19, 2019Thero John FPresident and CEOForm 4 sale274,454$6.2M10.5%Plan not statedSEC
Nov 12, 2019Ekman LarsDirectorForm 4 sale38,600$747k100.0%UnusualSEC
Nov 11, 2019Thero John FPresident and CEOForm 4 sale475,546$8.1M15.4%Plan not statedSEC
Nov 5, 2019Ekman LarsDirectorForm 4 sale6,400$115k100.0%UnusualSEC
Sep 3, 2019Ekman LarsDirectorForm 4 sale91,016$1.4M100.0%UnusualSEC
Jul 11, 2019Stack David MDirectorForm 4 sale51,991$1.2M100.0%UnusualSEC
Jul 5, 2019Zakrzewski Joseph SDirectorForm 4 sale100,000$2.4M54.2%UnusualSEC
Jul 3, 2019Berg AaronCHIEF COMMERCIAL OFFICERForm 4 sale98,814$2.1M73.1%UnusualSEC
Jul 1, 2019Kennedy Joseph TGeneral CounselForm 4 sale54,186$1.1M63.4%UnusualSEC
Jul 1, 2019Kalb Michael WayneSVP and CFOForm 4 sale50,000$984k70.6%UnusualSEC
Jun 24, 2019Berg AaronCHIEF COMMERCIAL OFFICERForm 4 sale113,195$2.1M75.7%UnusualSEC
Jun 18, 2019Zakrzewski Joseph SDirectorForm 4 sale100,000$1.9M54.2%UnusualSEC
May 31, 2019Kennedy Joseph TGeneral CounselForm 4 sale27,229$488k46.6%UnusualSEC
May 29, 2019Stack David MDirectorForm 4 sale33,799$624k100.0%UnusualSEC
May 17, 2019Stack David MDirectorForm 4 sale13,174$237k100.0%UnusualSEC
Apr 30, 2019Ketchum Steven BChief Scientific OfficerForm 4 sale9,541$178k2.6%Plan not statedSEC
Apr 30, 2019Kennedy Joseph TGeneral CounselForm 4 sale27,230$509k46.6%UnusualSEC
Apr 1, 2019Ketchum Steven BChief Scientific OfficerForm 4 sale9,542$191k2.6%Plan not statedSEC
Apr 1, 2019Kennedy Joseph TGeneral CounselForm 4 sale53,060$1.1M62.1%UnusualSEC
Mar 4, 2019Thero John FPresident and CEOForm 4 sale250,000$5.3M10.7%Plan not statedSEC
Mar 4, 2019Ekman LarsDirectorForm 4 sale135,377$2.9M100.0%UnusualSEC
Mar 1, 2019Ketchum Steven BChief Scientific OfficerForm 4 sale55,543$1.2M13.5%Plan not statedSEC
Mar 1, 2019Kalb Michael WayneSVP and CFOForm 4 sale100,000$2.2M83.0%UnusualSEC
Feb 28, 2019Kennedy Joseph TGeneral CounselForm 4 sale27,231$564k46.6%UnusualSEC
Feb 22, 2019Zakrzewski Joseph SDirectorForm 4 sale180,625$3.6M68.1%UnusualSEC
Feb 22, 2019Van Heek G JanDirectorForm 4 sale203,382$4.1M93.5%UnusualSEC
Feb 22, 2019Peterson KristineDirectorForm 4 sale163,500$3.3M100.0%UnusualSEC
Feb 22, 2019Kalb Michael WayneSVP and CFOForm 4 sale50,000$949k70.9%UnusualSEC
Feb 15, 2019Kalb Michael WayneSVP and CFOForm 4 sale25,000$439k54.9%UnusualSEC
Feb 1, 2019Ketchum Steven BChief Scientific OfficerForm 4 sale37,530$644k9.6%Plan not statedSEC
Jan 31, 2019Kennedy Joseph TGeneral CounselForm 4 sale42,624$745k57.7%UnusualSEC
Jan 24, 2019Kennedy Joseph TGeneral CounselForm 4 sale1M$18.5M100.0%UnusualSEC
Jan 11, 2019Kennedy Joseph TGeneral CounselForm 4 sale3,173$60k1.4%Plan not statedSEC
Jan 10, 2019Zakrzewski Joseph SDirectorForm 4 sale200,000$3.4M70.3%UnusualSEC
Jan 10, 2019Stack David MDirectorForm 4 sale125,504$2.3M100.0%UnusualSEC
Jan 10, 2019Ekman LarsDirectorForm 4 sale140,416$2.4M100.0%UnusualSEC
Jan 9, 2019Kalb Michael WayneSVP and CFOForm 4 sale200,000$3.1M92.0%UnusualSEC
Jan 2, 2019Zakrzewski Joseph SDirectorForm 4 sale526,500$6.9M86.2%UnusualSEC
Dec 31, 2018Kennedy Joseph TGeneral CounselForm 4 sale26,943$363k11.0%Plan not statedSEC
Dec 31, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale17,041$230k4.8%Plan not statedSEC
Nov 30, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale17,042$303k4.8%Plan not statedSEC
Nov 30, 2018Kennedy Joseph TGeneral CounselForm 4 sale23,306$415k9.7%Plan not statedSEC
Nov 12, 2018Thero John FPresident and CEOForm 4 sale607,611$11.6M22.5%Plan not statedSEC
Oct 31, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale17,042$353k4.8%Plan not statedSEC
Oct 31, 2018Kennedy Joseph TGeneral CounselForm 4 sale23,307$483k9.7%Plan not statedSEC
Oct 1, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale316,604$5.1M48.1%UnusualSEC
Oct 1, 2018Kennedy Joseph TGeneral CounselForm 4 sale50,249$845k18.7%Plan not statedSEC
Sep 25, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale879,241$9.8M72.0%UnusualSEC
Sep 24, 2018Zakrzewski Joseph SDirectorForm 4 sale500,000$5.3M68.9%UnusualSEC
Sep 24, 2018Kennedy Joseph TGeneral CounselForm 4 sale1.1M$11.4M83.2%UnusualSEC
Sep 24, 2018Kalb Michael WayneSVP and CFOForm 4 sale150,000$1.6M90.9%UnusualSEC
Jul 2, 2018Kennedy Joseph TGeneral CounselForm 4 sale26,942$81k59.4%UnusualSEC
Apr 3, 2018Kennedy Joseph TGeneral CounselForm 4 sale26,942$78k59.4%UnusualSEC
Jan 31, 2018Kennedy Joseph TGeneral CounselForm 4 sale44,857$167k70.9%UnusualSEC
Jan 23, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale135,205$596k48.8%UnusualSEC
Jan 17, 2018Kennedy Joseph TGeneral CounselForm 4 sale51,106$209k100.0%UnusualSEC
Jan 11, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale2,612$11k1.8%Plan not statedSEC
Jan 5, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale64,683$285k31.3%UnusualSEC
Jan 2, 2018Ketchum Steven BChief Scientific OfficerForm 4 sale128,257$545k47.5%UnusualSEC
Oct 5, 2017Ketchum Steven BChief Scientific OfficerForm 4 sale63,479$221k30.9%UnusualSEC
Jul 3, 2017Kennedy Joseph TGeneral CounselForm 4 sale307,911$1.2M100.0%UnusualSEC
Nov 9, 2016Kennedy Joseph TGeneral CounselForm 4 sale122,358$372k43.0%UnusualSEC
Oct 1, 2012Zakrzewski Joseph SChief Executive OfficerForm 4 sale150,000$1.9M57.3%UnusualSEC
Sep 4, 2012Gordon Carl LDirectorForm 4 sale233,700$3.4M97.6%UnusualSEC
Sep 4, 2012OrbiMed Capital GP III LLCDirectorForm 4 sale233,700$3.4M97.6%UnusualSEC
Jul 27, 2012Zakrzewski Joseph SChief Executive OfficerForm 4 sale150,000$2.1M57.3%UnusualSEC
Jul 27, 2012Thero John FPresidentForm 4 sale300,926$4.3M97.0%UnusualSEC
Jul 27, 2012Kennedy Joseph TSenior VP and General CounselForm 4 sale6,950$96k100.0%UnusualSEC
Jul 27, 2012Huff PaulChief Commercial OfficerForm 4 sale6,950$96k100.0%UnusualSEC
Jul 27, 2012Sedlack Stuart DSenior Vice PresidentForm 4 sale6,950$96k100.0%UnusualSEC
Jul 27, 2012Gordon Carl LDirectorForm 4 sale366,300$5.4M97.9%UnusualSEC
Jul 27, 2012Isaly Samuel DDirectorForm 4 sale366,300$5.4M97.9%UnusualSEC
Jun 27, 2012Huff PaulChief Commercial OfficerForm 4 sale50,000$749k100.0%UnusualSEC
Jun 19, 2012Gordon Carl LDirectorForm 4 sale617,100$8M98.2%UnusualSEC
Jun 19, 2012Orbimed Advisors LLCDirectorForm 4 sale617,100$8M98.2%UnusualSEC
Jun 18, 2012Huff PaulChief Commercial OfficerForm 4 sale163,025$2M100.0%UnusualSEC
Jun 7, 2012Huff PaulChief Commercial OfficerForm 4 sale16,725$202k100.0%UnusualSEC
May 29, 2012Zakrzewski Joseph SChief Executive OfficerForm 4 sale150,000$1.8M65.6%UnusualSEC
Apr 19, 2012Abingworth LLP10% ownerForm 4 sale4M$38.5M71.5%UnusualSEC
Apr 9, 2012Thero John FPresidentForm 4 sale150,926$1.5M100.0%UnusualSEC
Apr 3, 2012Abingworth LLP10% ownerForm 4 sale2.3M$25.3M29.1%UnusualSEC
Apr 3, 2012Healy JamesDirectorForm 4 sale2M$22M26.6%UnusualSEC
Mar 29, 2012Healy JamesDirectorForm 4 sale1M$11M11.7%Plan not statedSEC
Mar 23, 2012Zakrzewski Joseph SChief Executive OfficerForm 4 sale160,000$1.9M67.1%UnusualSEC
May 2, 2011Isaly Samuel DDirectorForm 4 sale132,900$2.1M88.5%UnusualSEC
May 2, 2011Gordon Carl LDirectorForm 4 sale132,900$2.1M88.5%UnusualSEC
Apr 25, 2011Van Heek G JanDirectorForm 4 sale30,000$497k64.8%UnusualSEC
Apr 21, 2011Gordon Carl LDirectorForm 4 sale750,000$12.5M97.6%UnusualSEC
Apr 21, 2011OrbiMed Capital GP III LLCDirectorForm 4 sale750,000$12.5M97.6%UnusualSEC
Apr 20, 2011Ahlholm Frederick WVice President FinanceForm 4 sale31,250$496k100.0%UnusualSEC
Apr 20, 2011Gordon Carl LDirectorForm 4 sale3.8M$58.2M99.3%UnusualSEC
Apr 20, 2011Isaly Samuel DDirectorForm 4 sale3.8M$58.2M99.3%UnusualSEC
Apr 19, 2011Soni PareshSVP and Head of DevelopmentForm 4 sale80,000$1.2M100.0%UnusualSEC
Apr 18, 2011Zakrzewski Joseph SChief Executive OfficerForm 4 sale300,000$4.7M82.5%UnusualSEC
Apr 18, 2011Van Heek G JanDirectorForm 4 sale3,000$50k13.4%Plan not statedSEC
Apr 18, 2011Abingworth LLP10% ownerForm 4 sale4.2M$62.1M34.6%UnusualSEC
Apr 4, 2011Ahlholm Frederick WVice President FinanceForm 4 sale31,250$234k100.0%UnusualSEC
Mar 29, 2011Healy JamesDirector, 10% ownerForm 4 sale424,900$3.1M4.8%Plan not statedSEC
Mar 28, 2011Gordon Carl LDirectorForm 4 sale173,000$1.3M73.8%UnusualSEC
Mar 28, 2011Orbimed Advisors LLCDirectorForm 4 sale173,000$1.3M73.8%UnusualSEC
Mar 25, 2011Healy JamesDirector, 10% ownerForm 4 sale575,100$4.3M6.0%Plan not statedSEC
Mar 21, 2011Gordon Carl LDirectorForm 4 sale77,000$543k55.0%UnusualSEC
Mar 21, 2011Orbimed Advisors LLCDirectorForm 4 sale77,000$543k55.0%UnusualSEC
Mar 15, 2011Gordon Carl LDirectorForm 4 sale225,000$1.7M77.9%UnusualSEC
Mar 15, 2011OrbiMed Capital GP III LLCDirectorForm 4 sale225,000$1.7M77.9%UnusualSEC
Mar 11, 2011Abingworth LLP10% ownerForm 4 sale2.8M$20.6M18.5%UnusualSEC
Mar 11, 2011Buatois Eric10% ownerForm 4 sale2M$15M17.4%Plan not statedSEC
Mar 10, 2011Sofinnova Venture Partners Vii L P10% ownerForm 4 sale637,000$4.6M5.2%Plan not statedSEC
Mar 8, 2011Abingworth LLP10% ownerForm 4 sale550,000$4.1M3.6%Plan not statedSEC
Mar 7, 2011Gordon Carl LDirectorForm 4 sale75,000$574k53.2%UnusualSEC
Mar 7, 2011OrbiMed Capital GP III LLCDirectorForm 4 sale75,000$574k53.2%UnusualSEC
Mar 4, 2011Abingworth LLP10% ownerForm 4 sale100,000$760k0.6%Plan not statedSEC
Mar 2, 2011Abingworth LLP10% ownerForm 4 sale1.2M$9.2M7.2%Plan not statedSEC
Mar 2, 2011OrbiMed Capital GP III LLCDirectorForm 4 sale245,000$1.9M78.6%UnusualSEC
Mar 2, 2011Gordon Carl LDirectorForm 4 sale245,000$1.9M78.6%UnusualSEC
Mar 1, 2011Abingworth LLP10% ownerForm 4 sale325,000$2.6M1.9%Plan not statedSEC
Feb 25, 2011Sofinnova Management VII, L.L.C.10% ownerForm 4 sale363,000$3M2.9%Plan not statedSEC
Feb 25, 2011Zakrzewski Joseph SChief Executive OfficerForm 4 sale60,000$490k52.8%UnusualSEC
Feb 22, 2011Zakrzewski Joseph SChief Executive OfficerForm 4 sale100,000$854k65.1%UnusualSEC
Feb 22, 2011Soni PareshSVP and Head of DevelopmentForm 4 sale120,000$1M100.0%UnusualSEC